0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Negative revenue growth while 0259.HK stands at 6.50%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.76%
Negative gross profit growth while 0259.HK is at 20.88%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.87%
Positive EBIT growth while 0259.HK is negative. John Neff might see a substantial edge in operational management.
46.87%
Operating income growth at 50-75% of 0259.HK's 87.48%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-112.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-112.61%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-114.85%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.05%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-14.84%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Negative OCF growth while 0259.HK is at 28.78%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-96.66%
Negative FCF growth while 0259.HK is at 81.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.83%
Negative 10Y revenue/share CAGR while 0259.HK stands at 605.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.53%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-33.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-2026.74%
Negative 10Y OCF/share CAGR while 0259.HK stands at 178.98%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-330.94%
Negative 5Y OCF/share CAGR while 0259.HK is at 177.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.08%
Negative 3Y OCF/share CAGR while 0259.HK stands at 1223.36%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Negative 10Y net income/share CAGR while 0259.HK is at 116.47%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.81%
Negative 5Y net income/share CAGR while 0259.HK is 1.34%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
631.56%
Equity/share CAGR of 631.56% while 0259.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
14.54%
Below 50% of 0259.HK's 69.37%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
3Y equity/share CAGR 1.25-1.5x 0259.HK's 14.63%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-92.85%
Cut dividends over 10 years while 0259.HK stands at 909.57%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0259.HK stands at 236.52%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 0259.HK invests at 101.91%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Firm’s AR is declining while 0259.HK shows 0.02%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.92%
We show growth while 0259.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.51%
Positive BV/share change while 0259.HK is negative. John Neff sees a clear edge over a competitor losing equity.
38.08%
Debt growth of 38.08% while 0259.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
-67.10%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.20%
We cut SG&A while 0259.HK invests at 4.62%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.